Warning: The NCBI web site requires JavaScript to function. more...
Developments in the clinical understanding of rheumatoid arthritis.
Smolen JS, Aletaha D.
Arthritis Res Ther. 2009;11(1):204. Epub 2009 Jan 30. Review.
Related citations
The assessment of disease activity in rheumatoid arthritis.
Clin Exp Rheumatol. 2010 May-Jun;28(3 Suppl 59):S18-27. Epub 2010 Jun 22. Review.
Progression in early rheumatoid arthritis.
Combe B.
Best Pract Res Clin Rheumatol. 2009 Feb;23(1):59-69. Review.
Disease activity measures for rheumatoid arthritis.
Dougados M, Aletaha D, van Riel P.
Clin Exp Rheumatol. 2007 Sep-Oct;25(5 Suppl 46):S22-9. Review.
The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical care.
Aletaha D, Smolen JS.
Best Pract Res Clin Rheumatol. 2007 Aug;21(4):663-75.
Activity assessments in rheumatoid arthritis.
Curr Opin Rheumatol. 2008 May;20(3):306-13. Review.
Monitoring rheumatoid arthritis.
Curr Opin Rheumatol. 2011 May;23(3):252-8. Review.
Treatment of rheumatoid arthritis: state of the art 2009.
van Vollenhoven RF.
Nat Rev Rheumatol. 2009 Oct;5(10):531-41. Review.
Limitations of a quantitative swollen and tender joint count to assess and monitor patients with rheumatoid arthritis.
Pincus T.
Bull NYU Hosp Jt Dis. 2008;66(3):216-23. Review.
Rheumatoid arthritis joint progression in sustained remission is determined by disease activity levels preceding the period of radiographic assessment.
Aletaha D, Funovits J, Breedveld FC, Sharp J, Segurado O, Smolen JS.
Arthritis Rheum. 2009 May;60(5):1242-9.
[Monitoring disease activity, adjustment of conventional treatment and prognosis in rheumatoid arthritis].
Grazio S.
Reumatizam. 2008;55(2):45-52. Review. Croatian.
[Measuring disease activity for rheumatoid arthritis].
Aletaha D, Stamm T, Smolen J.
Z Rheumatol. 2006 Mar;65(2):93-6, 98-102. Review. German.
Early rheumatoid arthritis: pitfalls in diagnosis and review of recent clinical trials.
Cannella AC, O'Dell JR.
Drugs. 2006;66(10):1319-37. Review.
New prospects for the treatment of rheumatoid arthritis.
Choy EH.
Expert Opin Investig Drugs. 1998 Jul;7(7):1087-97.
Long-term outcomes of rheumatoid arthritis.
Sokka T.
Curr Opin Rheumatol. 2009 May;21(3):284-90. Review.
Modulation of T-cell co-stimulation in rheumatoid arthritis: clinical experience with abatacept.
Laganà B, Vinciguerra M, D'Amelio R.
Clin Drug Investig. 2009;29(3):185-202. doi: 10.2165/00044011-200929030-00005. Review.
Looking through the 'window of opportunity': is there a new paradigm of podiatry care on the horizon in early rheumatoid arthritis?
Woodburn J, Hennessy K, Steultjens MP, McInnes IB, Turner DE.
J Foot Ankle Res. 2010 May 17;3:8.
Emerging new therapies in rheumatoid arthritis: what's next for the patient?
Leff L.
J Infus Nurs. 2006 Nov-Dec;29(6):326-37. Review.
Evaluation of early rheumatoid arthritis disease activity and outcome.
van Gestel AM, van Riel PL.
Baillieres Clin Rheumatol. 1997 Feb;11(1):49-63. Review.
Remission of rheumatoid arthritis: should we care about definitions?
Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-45-51. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on